Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.

about

Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.

Item

http://www.wikidata.org/entity/Q40233751

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Role of DNA gyrase and topoiso ...... olates and laboratory mutants.

@en

type

Item

label

Role of DNA gyrase and topoiso ...... olates and laboratory mutants.

@en

prefLabel

Role of DNA gyrase and topoiso ...... olates and laboratory mutants.

@en

P1476

Role of DNA gyrase and topoiso ...... olates and laboratory mutants.

@en

P2093

Anne Jolivet-Gougeon

http://www.w3.org/2001/XMLSchema#string

Martine Bonnaure-Mallet

http://www.w3.org/2001/XMLSchema#string

Thierry Fosse

http://www.w3.org/2001/XMLSchema#string

P2860

Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation.

Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Brain abscess associated with multidrug-resistant Capnocytophaga ochracea infection.

Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea.

Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001-2015

Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.

Multidrug-resistant oral Capnocytophaga gingivalis responsible for an acute exacerbation of chronic obstructive pulmonary disease: Case report and literature review.

Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin.

Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants.

High prevalence of β-lactam and macrolide resistance genes in human oral Capnocytophaga species.

P304

2208-2212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX119

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E Ehrmann

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28453633

http://www.w3.org/2001/XMLSchema#string